MET and non-small cell lung carcinoma: Herein, we report studies on the antitumor activity and the underlying mechanism of DFX117 against NSCLC cells NCI-H1975 (c-Met-amplified, PI3K-mutated, and EGFR-mutated cells) and A549 (KRAS mutated cells).